Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Barrett-Lee

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Cancer Treatment Reviews|October 5, 2010
Src-mediated regulation of homotypic cell adhesion: implications for cancer progression and opportunities for therapeutic interventionAnshu Wadhawan, Chris Smith, Robert I Nicholson, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 31, 2012
Psychological and immunological characteristics of fatigued women undergoing radiotherapy for early-stage breast cancerNicholas Courtier, Tina Gambling, Stephanie Enright, et al.
Trials|November 29, 2017
Can routine data be used to support cancer clinical trials? A historical baseline on which to build: retrospective linkage of data from the TACT (CRUK 01/001) breast cancer trial and the National Cancer Data RepositoryLucy Suzanne Kilburn, Maria Aresu, Jane Banerji, et al.
Current Medical Research and Opinion|June 15, 2007
An audit to determine the time taken to administer intravenous bisphosphonate infusions in patients diagnosed with metastatic breast cancer to bone in a hospital settingPeter Barrett-Lee, Danny Bloomfield, Lisa Dougherty, et al.
Breast Cancer Research and Treatment|April 1, 2010
Inhibition of focal adhesion kinase suppresses the adverse phenotype of endocrine-resistant breast cancer cells and improves endocrine response in endocrine-sensitive cellsStephen Hiscox, Peter Barnfather, Edd Hayes, et al.
Breast Cancer Research : BCR|December 6, 2008
Anti-oestrogens but not oestrogen deprivation promote cellular invasion in intercellular adhesion-deficient breast cancer cellsAnnabel C Borley, Stephen Hiscox, Julia Gee, et al.
Clinical Therapeutics|October 4, 2005
Cost-effectiveness of oral ibandronate versus IV zoledronic acid or IV pamidronate for bone metastases in patients receiving oral hormonal therapy for breast cancer in the United KingdomErwin De Cock, John Hutton, Peter Canney, et al.
The Oncologist|October 27, 2005
Management of cancer-related anemia in patients with breast or gynecologic cancer: new insights based on results from the European Cancer Anemia SurveyPeter Barrett-Lee, Carsten Bokemeyer, Pere Gascón, et al.
Endocrine-Related Cancer|August 1, 2013
Targeting focal adhesion kinase in ER+/HER2+ breast cancer improves trastuzumab responseGlorianne Lazaro, Chris Smith, Lindy Goddard, et al.
Frontiers in Oncology|July 6, 2016
Overexpression of Specific CD44 Isoforms Is Associated with Aggressive Cell Features in Acquired Endocrine ResistanceRebecca Bellerby, Chris Smith, Sue Kyme, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Cancer Treatment Reviews|October 5, 2010
Src-mediated regulation of homotypic cell adhesion: implications for cancer progression and opportunities for therapeutic interventionAnshu Wadhawan, Chris Smith, Robert I Nicholson, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 31, 2012
Psychological and immunological characteristics of fatigued women undergoing radiotherapy for early-stage breast cancerNicholas Courtier, Tina Gambling, Stephanie Enright, et al.
Trials|November 29, 2017
Can routine data be used to support cancer clinical trials? A historical baseline on which to build: retrospective linkage of data from the TACT (CRUK 01/001) breast cancer trial and the National Cancer Data RepositoryLucy Suzanne Kilburn, Maria Aresu, Jane Banerji, et al.
Current Medical Research and Opinion|June 15, 2007
An audit to determine the time taken to administer intravenous bisphosphonate infusions in patients diagnosed with metastatic breast cancer to bone in a hospital settingPeter Barrett-Lee, Danny Bloomfield, Lisa Dougherty, et al.
Breast Cancer Research and Treatment|April 1, 2010
Inhibition of focal adhesion kinase suppresses the adverse phenotype of endocrine-resistant breast cancer cells and improves endocrine response in endocrine-sensitive cellsStephen Hiscox, Peter Barnfather, Edd Hayes, et al.
Breast Cancer Research : BCR|December 6, 2008
Anti-oestrogens but not oestrogen deprivation promote cellular invasion in intercellular adhesion-deficient breast cancer cellsAnnabel C Borley, Stephen Hiscox, Julia Gee, et al.
Clinical Therapeutics|October 4, 2005
Cost-effectiveness of oral ibandronate versus IV zoledronic acid or IV pamidronate for bone metastases in patients receiving oral hormonal therapy for breast cancer in the United KingdomErwin De Cock, John Hutton, Peter Canney, et al.
The Oncologist|October 27, 2005
Management of cancer-related anemia in patients with breast or gynecologic cancer: new insights based on results from the European Cancer Anemia SurveyPeter Barrett-Lee, Carsten Bokemeyer, Pere Gascón, et al.
Endocrine-Related Cancer|August 1, 2013
Targeting focal adhesion kinase in ER+/HER2+ breast cancer improves trastuzumab responseGlorianne Lazaro, Chris Smith, Lindy Goddard, et al.
Frontiers in Oncology|July 6, 2016
Overexpression of Specific CD44 Isoforms Is Associated with Aggressive Cell Features in Acquired Endocrine ResistanceRebecca Bellerby, Chris Smith, Sue Kyme, et al.
Pageof 4